X4 Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, X4 Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $11.75. The average 1-year stock price forecast is 178.44% higher than the current stock price, while the lowest is $10 (+136.97%) and the highest is $13 (+208.06%).

Price Target: $11.75 (+178.44%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$10	$11.75	$12	$13
Change	+136.97%	+178.44%	+184.36%	+208.06%

Analyst Ratings

The average analyst rating for X4 Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	3	3	3	4
Buy	1	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	3	3	3	3	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Thomas Smith Leerink Partners	Leerink Partners	Buy Initiates $12	Buy	Initiates	$12	+184.36%	Jun 2, 2026
Michael Schmidt Guggenheim	Guggenheim	Buy Maintains $12	Buy	Maintains	$12	+184.36%	May 7, 2026

Financial Forecast

Revenue This Year

9.50M

from 35.11M

-72.94%

from 35.11M

Revenue Next Year

9.58M

from 9.50M

0.79%

from 9.50M

EPS This Year

-0.76

from -1.87

EPS Next Year

-0.91

from -0.76

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	2.56M	35.11M	9.50M
Revenue Growth	-	-	-	-	1,273.21%	-72.94%
Gross Profit	-	-	-	1.76M	29.36M	7.26M
Gross Margin	-	-	-	68.83%	83.60%	76.40%
Operating Income	-75.35M	-88.08M	-107.52M	-141.40M	-79.88M	-95.60M
Net Income	-88.70M	-93.87M	-101.17M	-37.45M	-79.20M	-98.38M
EPS	-	-	-	-	-1.87	-0.76
Free Cash Flow	-43.05M	-44.23M	-59.79M	-83.72M	-57.36M	-83.00M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	10.8M
Avg	9.5M
Low	7.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-69.2%
Avg	-72.9%
Low	-79.5%

EPS Forecast

EPS	2026	2027	2028
High	-0.67
Avg	-0.76
Low	-0.96

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-